A new UK Health Security Agency (UKHSA) to plan for, prevent and respond to external health threats such as infectious diseases will be led by Dr. Jenny Harries, the Government has announced.
The UKHSA – previously the National Institute for Health Protection – will be the UK leader for health security, providing intellectual, scientific and operational leadership at national and local level, as well as on the global stage. It will ensure the nation can respond quickly and at greater scale to deal with pandemics and future threats.
The primary focus for the UKHSA in its initial phase of operation will be the continued fight against the COVID-19 pandemic.
It will bring together the country’s cutting-edge capabilities in data analytics and genomic surveillance with scale testing and contact tracing capability – combining key elements of Public Health England with the Joint Biosecurity Centre (JBC), and NHS Test and Trace.
Formally established in April 2021, the UKHSA will be chaired by Ian Peters, currently chair of Barts Health NHS Trust and former chief executive of British Gas, managing director of NatWest Small Business Services, and chairman of several data-driven growth technology companies.
Dr. Harries has previously served on the Joint Committee for Vaccination and Immunisation (JCVI) and brings a wealth of public health knowledge and expertise gained from working in the NHS and local government at local, regional and national levels. She played central roles in the UK’s response to COVID, Ebola, Zika, monkeypox, MERS and the Novichok attacks.
Dr. Jenny Harries, incoming Chief Executive, UKHSA said: "The pandemic has put the UK’s health security capabilities in sharp focus and the UKHSA will change the way we approach health protection. With the creation of the UKHSA, we have an unprecedented opportunity to build on the scientific and operational strength that has been developed, learn from the past and further develop strong bonds with health protection leadership from global to local, to ensure we are ready for the challenges of the future.
"The UKHSA will be agile in its responses, maximise the benefits of high-quality data, be relentless in its mission to rapidly identify and respond to new threats, whilst working seamlessly with academia, scientists, industry and local communities. In starting this important work I want to pay tribute to the commitment and professionalism of all those colleagues who have worked so hard in NHS Test and Trace, in PHE and in the JBC. I look forward to building a diverse, dynamic and dedicated world-leading health security agency with them.
Ian Peters, incoming chair, UKHSA said: "I’m delighted to be joining UKHSA. We are at a watershed moment in history, dealing with a global pandemic and soon we’ll be moving our focus to preventing such health emergencies in future, while playing a key role in reducing health inequalities. The UKHSA will be at the heart of protecting the British people from health threats for decades to come.
"I do not underestimate the importance of this role and will lean on my recent years within the NHS, my experience in transforming major companies, and my insights in data-driven technology to ensure the UKHSA fulfils its vital purpose."
Dr. Harries will leave her role as deputy Chief Medical Officer for England in April to become UKHSA chief executive. She will take over from current executive chair of NHS Test and Trace, Baroness Dido Harding, after a handover period through April, while PHE’s Interim chief executive, Michael Brodie, will remain in post to lead delivery of PHE’s health improvement and healthcare public health functions and support the transition.
